OCRUP
DEAD

Serial Number

86654583

Owner

Inflamax Research Inc.

Attorney

Cathleen E. Stadecker

Filing Date

Jun 8, 2015

Add to watchlist:

No watchlists yet
View on USPTO

OCRUP Trademark

Serial Number: 86654583 • Registration: 5742358

OCRUP is a trademark filed by Inflamax Research Inc. on June 8, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Inflamax Research Inc. (3 trademarks)

1310 Fewster Drive
Mississauga, Ontario L4W1A4 , CA

Entity Type: 03

HILL TOP RESEARCH INCORPORATED (4 trademarks)

4711 34TH STREET NORTH
SAINT PETERSBURG, FL 33714

Entity Type: 03

Trademark Details

Filing Date

June 8, 2015

Registration Date

May 7, 2019

Published for Opposition

February 19, 2019

Cancellation Date

November 21, 2025

Goods & Services

Development of computer software for patient recruitment and scheduling for clinical trials; computer software support services, namely, troubleshooting of computer software problems and diagnosing of computer software problems; database development and maintenance; medical research services; consulting services, namely, study design services in the nature of providing medical and scientific research for clinical trials that are for medical and scientific research purposes, and development and support services in the nature of conducting clinical trials for others in the field of clinical trials for medical and scientific research

Clinical services, namely, patient scheduling in the nature of appointment scheduling services; business development and support services in the field of medical and scientific clinical trials, namely, business management and compilation of computerized databases for the clinical trials, posting of clinical trial notices for the purposes of recruiting patients, providing updates of recruiting metrics, and providing a dashboard of recruiting information for each clinical trial site and clinical research organization; design and set up of medical and scientific clinical trials based on objectives of the clinical trials

Computer software, namely, software for patient recruitment and scheduling for clinical trials, software for analysis of patient recruitment and scheduling for clinical trials, computer software for providing an internet website portal offering information in the field of medical research and clinical trials for medical and scientific research

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 21, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 7, 2024 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 20, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
May 7, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 19, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 30, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 7, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 7, 2018 GPRN
PRIORITY ACTION E-MAILED
Jul 7, 2018 GPRA
PRIORITY ACTION WRITTEN
Jul 7, 2018 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 10, 2018 ERSI
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 19, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 19, 2018 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 13, 2017 ASGN
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 10, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 10, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 10, 2017 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 8, 2017 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 8, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
May 8, 2017 GNSL
SUSPENSION LETTER WRITTEN
May 8, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 10, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 25, 2016 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 25, 2016 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 25, 2016 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 21, 2016 RCCK
ASSIGNED TO LIE
Oct 18, 2016 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 1, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 1, 2016 GNSL
SUSPENSION LETTER WRITTEN
Apr 1, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2015 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2015 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2015 CNRT
ASSIGNED TO EXAMINER
Sep 17, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2015 NWOS
NEW APPLICATION ENTERED
Jun 11, 2015 NWAP